To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning
Clinical trial NCT00226512 · WITHDRAWN
Trial details
- NCT number
- NCT00226512
- Sponsor
- Hadassah Medical Organization
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.